The Bridge Project is a collaboration between the Koch Institute and the Dana-Farber/Harvard Cancer Center (DF/HCC), designed to bring bioengineering, advanced cancer science, and clinical oncology together to solve today’s most challenging problems in cancer research and care.

To encourage the formation of cross-disciplinary teams, we occasionally hold informational sessions and workshops around complex translational problems in cancer. Check below for information about upcoming Bridge Project opportunities, or click the Events tab to view videos from previous events.

Bridge Project funding is currently being applied to any aspect of translational cancer research — with preference given to work related to issues of high unmet medical need, for which advances in and/or technologies for early detection, more accurate diagnosis, monitoring, treatment, and prevention are required. A subset of available funding will be awarded with preference for projects focused on drug discovery and development, brain cancer research and/or immunotherapy.

2021 Bridge Project request for applications (RFA) is now closed:

Full applications were due to by September 17, 2021, no later than 4PM. (Note: LOIs are no longer required.)

Teams were notified by December 1, 2021 whether they were selected as finalists and needed to prepare a presentation. Finalists presented as a team to the Bridge Project Review Committee; the date for team presentations was announced by late October.

Download the RFA here.

Please email with any questions.